483
GVK Biosciences Pvt. Ltd.GVK Biosciences Pvt. Ltd. – FDA 483, Mar 13, 2015
Record Details
An FDA inspection of Clinogent (Div of GVK Biosciences) in Hyderabad, India, a Clinical Pharmacological Unit, revealed significant deficiencies in record-keeping and study documentation. Observations included issues with electronic ECG records, lack of adverse event evaluations, missing drug screening assay information, and inadequate maintenance of correspondence files. These findings highlight concerns regarding data integrity and the proper conduct of clinical studies.
- Person
View Company Profile
ID · 5f43791a-4ab0-45af-9712-99c86ae216de
Other documents for GVK Biosciences Pvt. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.